UNSPSC 41115827: Urinalysis analyzers

UNSPSC 41115827 Urinalysis analyzers is a Commodity code covering diagnostic laboratory equipment and related consumables that state and local health departments, hospitals, and university research facilities procure for clinical testing and occupational health screening. Recent state and local opportunities show minimal direct procurement of urinalysis analyzers under this code; instead, issuing bodies are acquiring diagnostic systems across a broader spectrum of laboratory and clinical equipment categories. The most active recent solicitations in the health diagnostics space involve sole-source renewals with incumbent vendors for specialized testing platforms—such as the State of Illinois Department of Public Health Division of Laboratories' procurement of service coverage and reagent supply for Clear DX System LR-SR instruments (sole source to Clear Labs, $1.9 million over two years, contract period December 6, 2026 through December 5, 2028), and the City of Orlando's technical support and service contract for an Autoanalyzer 3-HR system (sole source to Seal Analytical, posted May 4, 2026, due May 11, 2026). These procurements reflect ongoing reliance on proprietary diagnostic platforms and the associated reagent bundles and maintenance agreements that accompany them, rather than standalone urinalysis analyzer units. Issuing bodies in recent opportunities span state health agencies, county governments, municipal health departments, and university systems; no pattern of repeat buyers specifically soliciting urinalysis analyzers emerges from the recent record.

Geographic concentration is limited to Illinois (State Department of Public Health), Florida (City of Orlando), and scattered single-jurisdiction procurements. The code shows little recent activity specifically targeting urinalysis analyzer procurement at the state and local level. Opportunities tagged to this code typically involve broader medical equipment families or specialized laboratory platforms for which urinalysis analysis is incidental to the primary testing scope—most notably the Illinois state procurement of Clear DX whole-genome sequencing instruments for SARS-CoV-2 and microbial surveillance, which includes urinalysis as a subordinate testing capability. No representative RFP, RFQ, IFB, or ITB for standalone urinalysis analyzers appears in the recent opportunities block. Vendors pursuing this Commodity code should monitor state and local health department capital equipment cycles and occupational health programs, where baseline medical surveillance often includes urinalysis screening, but should expect limited direct solicitation activity under this code alone—most procurement occurs bundled within broader diagnostic platform acquisitions or integrated laboratory service contracts.